Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 1
2000 2
2001 4
2002 3
2003 3
2004 1
2005 1
2006 1
2007 1
2009 2
2010 5
2011 2
2012 3
2013 5
2014 6
2015 2
2016 3
2017 4
2018 3
2019 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

53 results
Results by year
Filters applied: . Clear all
Page 1
Model-based drug development in oncology: what's next?
Bruno R, Mercier F, Claret L. Bruno R, et al. Among authors: claret l. Clin Pharmacol Ther. 2013 Apr;93(4):303-5. doi: 10.1038/clpt.2013.8. Clin Pharmacol Ther. 2013. PMID: 23511786
Reply to U.R. Mansmann et al and M.-W. An et al.
Claret L, Bruno R. Claret L, et al. J Clin Oncol. 2013 Dec 1;31(34):4374-5. doi: 10.1200/JCO.2013.52.5733. Epub 2013 Oct 28. J Clin Oncol. 2013. PMID: 24166517 No abstract available.
Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.
Hu B, Younes A, Westin JR, Turturro F, Claret L, Feng L, Fowler N, Neelapu S, Romaguera J, Hagemeister FB, Rodriguez MA, Samaniego F, Fayad LE, Copeland AR, Nastoupil LJ, Nieto Y, Fanale MA, Oki Y. Hu B, et al. Among authors: claret l. Leuk Lymphoma. 2018 Apr;59(4):863-870. doi: 10.1080/10428194.2017.1359741. Epub 2017 Aug 9. Leuk Lymphoma. 2018. PMID: 28792260 Clinical Trial.
53 results